by Jessica Casebolt | Jul 13, 2023 | Life Sciences, Tea Leaves
The Food and Drug Administration (FDA) is opening the way for more cancer drugs from China as the U.S. continues to deal with an ongoing shortage in key chemotherapy treatments. A spokesperson for the FDA confirmed Monday that the agency is permitting 10 additional...
by Jessica Casebolt | Jul 13, 2023 | Inequities and SDOH, Tea Leaves
KFF HealthNews shared an analysis of data on the state councils that wield immense power over how opioid abatement dollars are spent in various states. The data shows that councils are as unique as states are from one another. They vary in size, power, and the amount...
by Jessica Casebolt | Jul 13, 2023 | Public Health/Prevention, Tea Leaves
Half of U.S. adults skip important health screenings, according to a survey released by Aflac. The survey noted that women have a less positive outlook than men regarding their current and future health prospects. Skipping regular checkups is common among individuals...
by Jessica Casebolt | Jul 13, 2023 | Providers, Tea Leaves
The federal government will pay eligible hospitals in the 340B program $9 billion to offset payment cuts the Supreme Court ruled unlawful last year. In 2018, the Department of Health and Human Services (HHS) cut prescription drug payments for 340B-covered entity...
by Jessica Casebolt | Jul 13, 2023 | M&A, Tea Leaves
A federal judge on Wednesday granted Teladoc Health’s motion to dismiss a securities class-action suit against the telehealth company stemming from its merger with Livongo. The amended version of the complaint, originally filed as a putative class action against...
Recent Comments